Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|February 7, 2025
Xpert MTB/RIF Ultra-resistant and MTBDRplus-susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencingYonas Ghebrekristos, Aysha Ahmed, Natalie Beylis, et al.
Frontiers in Cellular and Infection Microbiology|September 28, 2020
Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB TherapyCaroline G G Beltran, Tiaan Heunis, James Gallant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2024
Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibilityErick Auma, Rencia Alberts, Brigitta Derendinger, et al.
Scientific Reports|September 27, 2024
Subtracting the background by reducing cell-free DNA's confounding effects on Mycobacterium tuberculosis quantitation and the sputum microbiomeCharissa C Naidoo, Rouxjeane Venter, Francesc Codony, et al.
The Lancet. Microbe|September 22, 2023
Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluationYonas T Ghebrekristos, Natalie Beylis, Chad M Centner, et al.
Journal of Clinical Microbiology|August 21, 2025
AveloMask, a novel breath aerosol collection kit for airborne Mycobacterium tuberculosis: a proof-of-principle assessmentPatricia Risch, Tobias Broger, Zandile Booi, et al.
Pageof 3